THE HUPO Human Plasma Proteome Project

The Human Proteomics Organization (HUPO) Human Plasma Proteome Project (PPP) is a prominent example of the inherently collaborative nature of the overall community effort to characterize the proteome of humans in health and disease. The PPP Pilot Phase, called “Exploring the Human Plasma Proteome”, engaged 55 laboratories, four technical committees, and vendors and sponsors on an international scale. Among other outcomes, the PPP generated a Core Dataset of 3020 proteins identified with two or more peptides, fully accessible at EBI/PRIDE, ISB/PeptideAtlas, and University of Michigan websites, a rich resource for follow‐on analyses. The PPP provided extensive annotation, correlation of number of peptides with protein concentrations measured by immunoassay, an algorithm for choice of a representative protein for multiple proteins matching a given peptide, and independent analyses from the raw spectra. The next phase of the PPP will emphasize standardized procedures for specimen handling, potent new technology platforms for discovery and for targeted proteomics, and robust informatics efforts, including comparative analyses of other biofluids.

[1]  Gilbert S. Omenn,et al.  The Future: Translation from Discovery to the Clinic – Roles of HUPO and Industry in Biomarker Discovery , 2008 .

[2]  Naoyuki Taniguchi,et al.  Comparison of the methods for profiling glycoprotein glycans--HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study. , 2007, Glycobiology.

[3]  Lennart Martens,et al.  Annotating the human proteome: beyond establishing a parts list. , 2007, Biochimica et biophysica acta.

[4]  M. Girolami,et al.  Clinical proteomics: A need to define the field and to begin to set adequate standards , 2007, Proteomics. Clinical applications.

[5]  C. Schaefer,et al.  Analysis of the human serum proteome , 2004, Clinical Proteomics.

[6]  D. States,et al.  The Human Plasma and Serum Proteome , 2007 .

[7]  V. Thongboonkerd.  Proteomics of human body fluids : principles, methods, and applications , 2007 .

[8]  G. Omenn.  Exploring the Human Plasma Proteome: OMENN:HUMAN PLASMA PROTEO O-BK , 2006 .

[9]  Naoyuki Taniguchi,et al.  Decoding sugar functions by identifying target glycoproteins. , 2006, Current opinion in structural biology.

[10]  Henning Hermjakob,et al.  A Reagent Resource to Identify Proteins and Peptides of Interest for the Cancer Community , 2006, Molecular & Cellular Proteomics.

[11]  G. Omenn.  Strategies for plasma proteomic profiling of cancers , 2006, Proteomics.

[12]  G. Omenn,et al.  Standards for Plasma and Serum Protoemics in Early Cancer Detection: A Needs Assessment Report From the NIST-NCI SMART Workshop, August 18-19, 2005 | NIST , 2006 .

[13]  Lennart Martens,et al.  HUPO Brain Proteome Project: Summary of the pilot phase and introduction of a comprehensive data reprocessing strategy , 2006, Proteomics.

[14]  G. Omenn,et al.  Standards for plasma and serum proteomics in early cancer detection: a needs assessment report from the national institute of standards and technology--National Cancer Institute Standards, Methods, Assays, Reagents and Technologies Workshop, August 18-19, 2005. , 2006, Clinical chemistry.

[15]  M. Mann,et al.  The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins , 2006, Genome Biology.

[16]  Matthias Mann,et al.  Identification of 491 proteins in the tear fluid proteome reveals a large number of proteases and protease inhibitors , 2006, Genome Biology.

[17]  Damian Fermin,et al.  Novel gene and gene model detection using a whole genome open reading frame analysis in proteomics , 2006, Genome Biology.

[18]  R. Aebersold,et al.  Mass Spectrometry and Protein Analysis , 2006, Science.

[19]  R. Aebersold,et al.  Dynamic Spectrum Quality Assessment and Iterative Computational Analysis of Shotgun Proteomic Data , 2006, Molecular & Cellular Proteomics.

[20]  Leigh Anderson,et al.  Quantitative Mass Spectrometric Multiple Reaction Monitoring Assays for Major Plasma Proteins* , 2006, Molecular & Cellular Proteomics.

[21]  Fuchu He,et al.  The Human Liver Proteome Project (HLPP) Workshop during the 4th HUPO World Congress , 2006, Proteomics.

[22]  S. Hanash,et al.  Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study , 2006, Nature Biotechnology.

[23]  A. Olshen,et al.  Differential exoprotease activities confer tumor-specific serum peptidome patterns. , 2005, The Journal of clinical investigation.

[24]  Matthias Mann,et al.  Large-scale and high-confidence proteomic analysis of human seminal plasma , 2006, Genome Biology.

[25]  Graham B. I. Scott,et al.  HUPO Plasma Proteome Project specimen collection and handling: Towards the standardization of parameters for plasma proteome samples , 2005, Proteomics.

[26]  William S Hancock,et al.  A study of glycoproteins in human serum and plasma reference standards (HUPO) using multilectin affinity chromatography coupled with RPLC‐MS/MS , 2005, Proteomics.

[27]  Peipei Ping,et al.  Cardiovascular‐related proteins identified in human plasma by the HUPO Plasma Proteome Project Pilot Phase , 2005, Proteomics.

[28]  D. Speicher,et al.  Depletion of multiple high‐abundance proteins improves protein profiling capacities of human serum and plasma , 2005, Proteomics.

[29]  O John Semmes,et al.  Analysis of Human Proteome Organization Plasma Proteome Project (HUPO PPP) reference specimens using surface enhanced laser desorption/ionization‐time of flight (SELDI‐TOF) mass spectrometry: Multi‐institution correlation of spectra and identification of biomarkers , 2005, Proteomics.

[30]  Ilan Beer,et al.  Centralized data analysis of a large interlaboratory proteomics project: A feasibility study , 2005, Proteomics.

[31]  D. Speicher,et al.  A novel four‐dimensional strategy combining protein and peptide separation methods enables detection of low‐abundance proteins in human plasma and serum proteomes , 2005, Proteomics.

[32]  Akhilesh Pandey,et al.  Plasma Proteome Database as a resource for proteomics research , 2005, Proteomics.

[33]  H. Tammen,et al.  Peptidomic analysis of human blood specimens: Comparison between plasma specimens and serum by differential peptide display , 2005, Proteomics.

[34]  Nichole L. King,et al.  Human Plasma PeptideAtlas , 2005, Proteomics.

[35]  G. Omenn,et al.  Exploring the Human Plasma Proteome , 2005, Proteomics.

[36]  Akhilesh Pandey,et al.  A functional annotation of subproteomes in human plasma , 2005, Proteomics.

[37]  Hong Wang,et al.  A wide range of protein isoforms in serum and plasma uncovered by a quantitative intact protein analysis system , 2005, Proteomics.

[38]  Gilbert S Omenn,et al.  An evaluation, comparison, and accurate benchmarking of several publicly available MS/MS search algorithms: Sensitivity and specificity analysis , 2005, Proteomics.

[39]  Gilbert S Omenn,et al.  Immunoassay and antibody microarray analysis of the HUPO Plasma Proteome Project reference specimens: Systematic variation between sample types and calibration of mass spectrometry data , 2005, Proteomics.

[40]  Chris F. Taylor,et al.  Data management and preliminary data analysis in the pilot phase of the HUPO Plasma Proteome Project , 2005, Proteomics.

[41]  Eugene A. Kapp,et al.  Overview of the HUPO Plasma Proteome Project: Results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly‐available database , 2005, Proteomics.

[42]  R. Aebersold,et al.  Scoring proteomes with proteotypic peptide probes , 2005, Nature Reviews Molecular Cell Biology.

[43]  J. A. Taylor,et al.  Informatics for protein identification by mass spectrometry. , 2005, Methods.

[44]  A. Tsugita,et al.  Two‐dimensional electrophoretic profiling of normal human kidney glomerulus proteome and construction of an extensible markup language (XML)‐based database , 2005, Proteomics.

[45]  D. Ransohoff.  Lessons from controversy: ovarian cancer screening and serum proteomics. , 2005, Journal of the National Cancer Institute.

[46]  D. Ransohoff.  Bias as a threat to the validity of cancer molecular-marker research , 2005, Nature reviews. Cancer.

[47]  M. Mann,et al.  Improved peptide identification in proteomics by two consecutive stages of mass spectrometric fragmentation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[48]  D. Hochstrasser,et al.  Industrial‐scale proteomics: From liters of plasma to chemically synthesized proteins , 2004, Proteomics.

[49]  E. Birney,et al.  The International Protein Index: An integrated database for proteomics experiments , 2004, Proteomics.

[50]  Ruedi Aebersold,et al.  The Need for Guidelines in Publication of Peptide and Protein Identification Data , 2004, Molecular & Cellular Proteomics.

[51]  E. Petricoin,et al.  An investigation into the human serum “interactome” , 2004, Electrophoresis.

[52]  Gilbert S Omenn,et al.  The Human Proteome Organization Plasma Proteome Project pilot phase: Reference specimens, technology platform comparisons, and standardized data submissions and analyses , 2004, Proteomics.

[53]  Ronald J Moore,et al.  Ultra-high-efficiency strong cation exchange LC/RPLC/MS/MS for high dynamic range characterization of the human plasma proteome. , 2004, Analytical chemistry.

[54]  R. Aebersold,et al.  A statistical model for identifying proteins by tandem mass spectrometry. , 2003, Analytical chemistry.

[55]  Rolf Apweiler,et al.  The Proteomics Standards Initiative , 2003, Proteomics.

[56]  Ruedi Aebersold,et al.  Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry , 2003, Nature Biotechnology.

[57]  Ruedi Aebersold,et al.  Constellations in a cellular universe , 2003, Nature.

[58]  David Moher,et al.  The STARD Statement for Reporting Studies of Diagnostic Accuracy: Explanation and Elaboration , 2003, Annals of Internal Medicine [serial online].

[59]  N. Anderson,et al.  The Human Plasma Proteome: History, Character, and Diagnostic Prospects , 2003, Molecular & Cellular Proteomics.

[60]  Ronald J. Moore,et al.  Toward a Human Blood Serum Proteome , 2002, Molecular & Cellular Proteomics.

[61]  A. Nesvizhskii,et al.  Experimental protein mixture for validating tandem mass spectral analysis. , 2002, Omics : a journal of integrative biology.